Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
Ikerian applies data and AI to identify biomarkers linked to chronic and systemic disorders, aggregate clinical insights, and support treatment decisions. The company serves healthcare stakeholders and drug developers by curating information and optimizing clinical workflows and operations.
2 investors
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.
2 investors
Illimis Therapeutics is a biotech company developing therapeutics for intractable diseases, including GAIA-Aฮฒ, a treatment aimed at improving Alzheimer's disease by clearing beta-amyloid via an efferocytosis-based mechanism that avoids the ARIA side effects of existing treatments. The company focuses on translating life science research into medicines for patients.
2 investors
Illumi Medical is a medical device company based in Japan with research facilities in Nagoya and Koriyama. The page provides company contact and location information but does not specify the company's product offerings or business focus.
2 investors
Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health. The firm provides capital, sequencing access, mentorship, and lab capabilities to portfolio companies through its Labs program.
2 investors
Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
2 investors
Imel Biotherapeutics is a biotech company focused on mitochondrial biology, targeting mitochondrial dysfunction implicated in aging, cellular senescence, and T cell exhaustion in the elderly population.
2 investors
Imio makes Re-Gen, a freeze-dried microbial powder applied to crop residue for row crops such as corn, helping farmers unlock NPK nutrient value and increase yields. The product is aimed at agricultural growers seeking fertilizer savings and higher output per acre.
2 investors
Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments. The company is an ETH Zรผrich spin-off focused on precision medicine and gene editing approaches for genetic disease intervention.
2 investors
ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.
2 investors
Immuneel Therapeutics develops and manufactures cell-based immunotherapies, including CAR-T therapies, for cancer patients, with in-house cGMP lentiviral vector manufacturing. The company aims to make next-generation cell therapies affordable and accessible in India, with a global outlook.
2 investors
Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.
2 investors
Immunito AI is an in-silico antibody discovery company that combines artificial intelligence with an in-house biological lab to speed up and improve the discovery of antibodies. It serves the biotech and biopharmaceutical industry.
2 investors
A nonprofit organization that uses machine learning to accelerate vaccine development. The project applies AI techniques to immunology research and vaccine design.
2 investors
Immunocore is a biotechnology company developing T cell receptor (TCR) based immunomodulating therapies for patients with cancer, infectious diseases, and autoimmune diseases.
2 investors
NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.
2 investors
Immunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
2 investors
Immunomic Therapeutics develops nucleic acid immunotherapy platforms, particularly self-amplifying RNA and plasmid DNA vaccines, for cancer treatment, allergies, and animal health applications. The company's UNITEยฎ platform leverages lysosomal targeting technology to generate immune responses against CMV, HPV, and other tumor-associated antigens across multiple cancer types and allergic conditions.
2 investors
ImpacFat develops stem-cell based omega-3 fish fat technology as a cultivated, sustainable alternative for the food industry. The Singapore-founded company works in the cultivated seafood and cellular agriculture space and is establishing an R&D hub in Tokyo, Japan.
2 investors
ImYoo develops a platform that enables continuous, scalable biological data collection from patients outside traditional clinical settings to support precision medicine research and drug development. The platform addresses data gaps in healthcare by gathering longitudinal biological measurements from diverse patient populations to improve diagnostics, treatment matching, and clinical trial outcomes.
2 investors
In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience. The company serves pet owners and veterinarians in the animal health market.
2 investors
Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.
2 investors
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
2 investors
Indomo Tx develops drug delivery technology focused on dermatology and consumer health, aiming to improve patient outcomes by helping individuals manage their own health. It is backed by a team with expertise in drug delivery, dermatology, and clinical and pharmaceutical fields.
2 investors